Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.3390/cancers13164180
|View full text |Cite
|
Sign up to set email alerts
|

Insights into the Evolving Roles of Circular RNAs in Cancer

Abstract: The majority of RNAs transcribed from the human genome have no coding capacity and are termed non-coding RNAs (ncRNAs). It is now widely accepted that ncRNAs play key roles in cell regulation and disease. Circular RNAs (circRNAs) are a form of ncRNA, characterised by a closed loop structure with roles as competing endogenous RNAs (ceRNAs), protein interactors and transcriptional regulators. Functioning as key cellular regulators, dysregulated circRNAs have a significant impact on disease progression, particula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 66 publications
0
12
0
Order By: Relevance
“…The above characteristics make circRNAs have the potential to become biomarkers, so circRNAs have attracted the attention of many researchers. As reported, the abnormal expression of circRNAs was related to the pathogenesis of many diseases [4,10]. CircRNAs could interfere with disease progression by affecting various biological functions such as cell proliferation, metastasis, metabolism and chemotherapy resistance [6,24,25].…”
Section: Introductionmentioning
confidence: 89%
“…The above characteristics make circRNAs have the potential to become biomarkers, so circRNAs have attracted the attention of many researchers. As reported, the abnormal expression of circRNAs was related to the pathogenesis of many diseases [4,10]. CircRNAs could interfere with disease progression by affecting various biological functions such as cell proliferation, metastasis, metabolism and chemotherapy resistance [6,24,25].…”
Section: Introductionmentioning
confidence: 89%
“…Tumor cells can secrete 10 times more exosomes than other cells [119]. In the serum and urine exosomes of bladder cancer, circPRMT5 sponges miR-30c through the snail1/E-cadherin pathway to enhance the EMT process, while circ-PDE8A, from hepatic metastatic PDAC cells, acts as a sponge of miR-338 to up-regulate MACC1 and then increases the invasive growth of PDAC cells, thus affecting the tumor progression [120]. Therefore, circRNAs play potentially important roles in the tumor microenvironment through interacting miRNAs, and a circRNA-associated ceRNA network may be a suitable approach to screening a novel biomarker for cancer.…”
Section: Potential Roles Of Circrnas In Tumor Microenvironment Throug...mentioning
confidence: 99%
“…Several excellent reviews have recently covered a variety of strategies to manipulate the medicinal potential of ncRNAs by using small interfering RNAs (siRNAs), antisense oligonucleotides (ASOs), short hairpin RNAs (shRNAs), anti-microRNAs (anti-miRNAs), miRNA mimics, miRNA sponges, therapeutic circular RNAs (cirRNAs), and CRISPR-Cas9based gene editing [6,20,21]. The value of developing therapeutic targeting of ncRNA, while obvious, faces significant obstacles associated with specificity, delivery, and tolerability.…”
Section: Noncoding Rna Therapeutics Approved By Regulatory Agenciesmentioning
confidence: 99%